Serum-free stable transfection and production of recombinant human proteins in human cell lines
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 6, 2016
Issued Date -
N/A
app pub date -
Feb 1, 2016
filing date -
Jun 30, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The present invention relates to an improved method for the serum-free production of an immortalized human cell line stably transfected under serum-free conditions with a specific vector carrying the gene coding for the protein of interest. Furthermore the invention relates to a production cell line obtained by said method, a production method for said protein of interest utilizing said production cell line, and the specific vector carrying the gene of interest itself.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
- 2016 Application Filing Year
- C12P Class
- 1834 Applications Filed
- 1256 Patents Issued To-Date
- 68.49 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- C12P Class
- 0 % this patent is cited more than
- 9 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jun 6, 2028 |
